Event Detail
DIA Webinar: Worldwide Regulatory Landscape: Current Regulatory Initiatives in the US, Canada and EU
July 15, 2009
- Webinar PA UNITED STATES
DIA - Drug Information Association
Part 1 of "Clinical Trial Landscape in India" Webinar Series Overview India has been one of the major global players in the development of generic drugs, continues togain visibility in the development of new drugs, and is one of the major geographies for conducting multinational clinical trials. Learn how intergovernmental initiatives and partnerships between India’s Drug Regulatory Department (DCGI office) and USFDA, Health Canada, MHRA and EMEA would add to India’s role in the development of new medicines. Learning Objectives: At the conclusion of this webinar, participants should be able to: * Identify initiatives taken by FDA, EMEA, MHRA and Health Canada with DCGI office * Recognize what potential impact these initiatives may have in the advancement of clinical research * Discuss potential future initiatives Speakers Include: Satish C. Tripathi, PhD, MPharm, MS, RAC President and CEO Biomedical Consulting International, Inc., United States Albinus M D'Sa Compliance Officer FDA/CDER, United States Gopalan Narayanan, MD Head, Biologicals and Biotechnology Unit MHRA, United Kingdom Supriya Sharma, MD, MPH, FRCPC Director General, Health Products and Food Branch Health Canada, Canada IACET to offer .2 CEUs for this program. Event Code: 09234